1. Home
  2. RGEN vs MASI Comparison

RGEN vs MASI Comparison

Compare RGEN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MASI
  • Stock Information
  • Founded
  • RGEN 1981
  • MASI 1989
  • Country
  • RGEN United States
  • MASI United States
  • Employees
  • RGEN N/A
  • MASI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MASI Medical/Dental Instruments
  • Sector
  • RGEN Health Care
  • MASI Health Care
  • Exchange
  • RGEN Nasdaq
  • MASI Nasdaq
  • Market Cap
  • RGEN 8.0B
  • MASI 8.2B
  • IPO Year
  • RGEN N/A
  • MASI 2007
  • Fundamental
  • Price
  • RGEN $126.50
  • MASI $155.62
  • Analyst Decision
  • RGEN Buy
  • MASI Buy
  • Analyst Count
  • RGEN 12
  • MASI 6
  • Target Price
  • RGEN $172.67
  • MASI $187.00
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • MASI 650.0K
  • Earning Date
  • RGEN 04-29-2025
  • MASI 05-06-2025
  • Dividend Yield
  • RGEN N/A
  • MASI N/A
  • EPS Growth
  • RGEN N/A
  • MASI N/A
  • EPS
  • RGEN N/A
  • MASI N/A
  • Revenue
  • RGEN $650,429,000.00
  • MASI $2,126,800,000.00
  • Revenue This Year
  • RGEN $13.93
  • MASI N/A
  • Revenue Next Year
  • RGEN $14.35
  • MASI $7.74
  • P/E Ratio
  • RGEN N/A
  • MASI N/A
  • Revenue Growth
  • RGEN 4.88
  • MASI 16.68
  • 52 Week Low
  • RGEN $102.97
  • MASI $101.61
  • 52 Week High
  • RGEN $182.52
  • MASI $194.88
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • MASI 46.76
  • Support Level
  • RGEN $123.10
  • MASI $151.13
  • Resistance Level
  • RGEN $135.47
  • MASI $165.28
  • Average True Range (ATR)
  • RGEN 6.98
  • MASI 5.14
  • MACD
  • RGEN -0.97
  • MASI -0.26
  • Stochastic Oscillator
  • RGEN 25.20
  • MASI 49.65

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MASI Masimo Corporation

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Share on Social Networks: